Effects of Physiotherapy Via Telerehabilitation in Patients With COVID-19

Not Applicable

Completed

• Conditions: Long COVID-19; Cardiopulmonary Function; COVID-19; Physical Function
• Interventions: Behavioral: Exercise training

• Registration Number: NCT06251011
• Lead Sponsor: Chulabhorn Hospital

Brief Summary

This study aims to evaluate the effects of Physiotherapy Via Video Calls on Cardiopulmonary Functions, Physical Function, Cognitive Function, Activity Daily Livings, and Quality of Life in Patients With COVID-19.

Detailed Description

A 2-armed, parallel-group, randomized controlled trial was conducted at Chulabhorn Hospital, Thailand on a convenience sample of patients who tested positive for COVID-19 using RT-PCR.

Study Timeline

• Study First Submitted: 2024-02-07
• Study First Submitted QC: 2024-02-07
• Study Start: 2024-02-09
• Study First Posted: 2024-02-09
• Status Verified: 2024-06
• Primary Completion: 2024-06-01
• Study Completion: 2024-06-04
• Last Update Submitted: 2024-06-04
• Last Update Posted: 2024-06-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Age between 20-60 years old
• Positive in COVID-19 testing
• Good communication and understanding
• Independent mobility

Exclusion Criteria

• Cannot complete the study protocol

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Physiotherapy group	Exercise training	Receive the physical therapy training via video call (Pulmonary training, Calisthenic exercise, Upper and lower limbs strengthening exercise, Core stabilizer exercise, Aerobic exercise) at day 3, 6, 9, 12, 16, and 21 after positive in COVID-19 testing and also receive advise and a leaflet for cardiopulmonary rehabilitation.

Primary Outcome Measures

Name	Time	Method
Anxiety and depression	at day 3 and 21 after positive in COVID-19 testing	using Hospital Anxiety and Depression Scale (HADS) The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). A total subscale score of \>8 points out of a possible 21 denotes considerable symptoms of anxiety or depression.
Insomnia	at day 3 and 21 after positive in COVID-19 testing	using Insomnia Severity Index (ISI) The final score ranges between zero and 28 points. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).
Cognitive function	at day 3 and 21 after positive in COVID-19 testing	using Thai Mental State Examination The final score ranges between zero and 30 points. A score of 25 or higher is classed as normal. If the score is below 24, the result is usually considered to be abnormal, indicating possible cognitive impairment.
Muscle strength	at day 3 and 21 after positive in COVID-19 testing	using 1-minute sit to stand
Cardiopulmonary function	at day 28 and 90 after positive in COVID-19 testing	using Cardiopulmonary exercise testing (CPET)
Patient's quality of life	at day 3 and 21 after positive in COVID-19 testing	using the The World Health Organization Quality of Life (WHOQOL-BREF-THAI) 26 items; the final score ranges from 24-120; higher score means participants satisfied with the quality of life.
Functional capacity	at day 3 and 21 after positive in COVID-19 testing	using Duke Activity status index The final score ranges between zero and 58.2 points; The higher the score, the better the functional capacity.

Trial Locations

Locations (1)

Chulabhorn hospital; 🇹🇭 Lak Si, Bangkok, Thailand